142 related articles for article (PubMed ID: 32747660)
21. Molecular and epigenetic features of melanomas and tumor immune microenvironment linked to durable remission to ipilimumab-based immunotherapy in metastatic patients.
Seremet T; Koch A; Jansen Y; Schreuer M; Wilgenhof S; Del Marmol V; Liènard D; Thielemans K; Schats K; Kockx M; Van Criekinge W; Coulie PG; De Meyer T; van Baren N; Neyns B
J Transl Med; 2016 Aug; 14(1):232. PubMed ID: 27484791
[TBL] [Abstract][Full Text] [Related]
22. Differential expression of S100 protein subtypes in malignant melanoma, and benign and malignant peripheral nerve sheath tumors.
Nonaka D; Chiriboga L; Rubin BP
J Cutan Pathol; 2008 Nov; 35(11):1014-9. PubMed ID: 18547346
[TBL] [Abstract][Full Text] [Related]
23. Chromosome band 9p21 is frequently altered in malignant peripheral nerve sheath tumors: studies of CDKN2A and other genes of the pRB pathway.
Berner JM; Sørlie T; Mertens F; Henriksen J; Saeter G; Mandahl N; Brøgger A; Myklebost O; Lothe RA
Genes Chromosomes Cancer; 1999 Oct; 26(2):151-60. PubMed ID: 10469453
[TBL] [Abstract][Full Text] [Related]
24. Involvement of Aryl hydrocarbon receptor in myelination and in human nerve sheath tumorigenesis.
Shackleford G; Sampathkumar NK; Hichor M; Weill L; Meffre D; Juricek L; Laurendeau I; Chevallier A; Ortonne N; Larousserie F; Herbin M; Bièche I; Coumoul X; Beraneck M; Baulieu EE; Charbonnier F; Pasmant E; Massaad C
Proc Natl Acad Sci U S A; 2018 Feb; 115(6):E1319-E1328. PubMed ID: 29351992
[TBL] [Abstract][Full Text] [Related]
25. Epigenetic Silencing of SPINT2 Promotes Cancer Cell Motility via HGF-MET Pathway Activation in Melanoma.
Hwang S; Kim HE; Min M; Raghunathan R; Panova IP; Munshi R; Ryu B
J Invest Dermatol; 2015 Sep; 135(9):2283-2291. PubMed ID: 25910030
[TBL] [Abstract][Full Text] [Related]
26. The Cellular Retinoic Acid Binding Protein 2 Promotes Survival of Malignant Peripheral Nerve Sheath Tumor Cells.
Fischer-Huchzermeyer S; Dombrowski A; Hagel C; Mautner VF; Schittenhelm J; Harder A
Am J Pathol; 2017 Jul; 187(7):1623-1632. PubMed ID: 28502478
[TBL] [Abstract][Full Text] [Related]
27. Genome-wide DNA methylation profile identified a unique set of differentially methylated immune genes in oral squamous cell carcinoma patients in India.
Basu B; Chakraborty J; Chandra A; Katarkar A; Baldevbhai JRK; Dhar Chowdhury D; Ray JG; Chaudhuri K; Chatterjee R
Clin Epigenetics; 2017; 9():13. PubMed ID: 28174608
[TBL] [Abstract][Full Text] [Related]
28. Higher methylation subtype of malignant melanoma and its correlation with thicker progression and worse prognosis.
Yamamoto Y; Matsusaka K; Fukuyo M; Rahmutulla B; Matsue H; Kaneda A
Cancer Med; 2020 Oct; 9(19):7194-7204. PubMed ID: 32406600
[TBL] [Abstract][Full Text] [Related]
29. Impact of DNA methyltransferases on the epigenetic regulation of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) receptor expression in malignant melanoma.
Venza M; Visalli M; Catalano T; Fortunato C; Oteri R; Teti D; Venza I
Biochem Biophys Res Commun; 2013 Nov; 441(4):743-50. PubMed ID: 24211571
[TBL] [Abstract][Full Text] [Related]
30. CpG island methylation profiling in human melanoma cell lines.
Tellez CS; Shen L; Estécio MR; Jelinek J; Gershenwald JE; Issa JP
Melanoma Res; 2009 Jun; 19(3):146-55. PubMed ID: 19441164
[TBL] [Abstract][Full Text] [Related]
31. NF1 deficiency causes Bcl-xL upregulation in Schwann cells derived from neurofibromatosis type 1-associated malignant peripheral nerve sheath tumors.
Park HJ; Lee SJ; Sohn YB; Jin HS; Han JH; Kim YB; Yim H; Jeong SY
Int J Oncol; 2013 Feb; 42(2):657-66. PubMed ID: 23292448
[TBL] [Abstract][Full Text] [Related]
32. MMP-9 overexpression is associated with intragenic hypermethylation of MMP9 gene in melanoma.
Falzone L; Salemi R; Travali S; Scalisi A; McCubrey JA; Candido S; Libra M
Aging (Albany NY); 2016 May; 8(5):933-44. PubMed ID: 27115178
[TBL] [Abstract][Full Text] [Related]
33. Molecular profiling of malignant peripheral nerve sheath tumors associated with neurofibromatosis type 1, based on large-scale real-time RT-PCR.
Lévy P; Vidaud D; Leroy K; Laurendeau I; Wechsler J; Bolasco G; Parfait B; Wolkenstein P; Vidaud M; Bièche I
Mol Cancer; 2004 Jul; 3():20. PubMed ID: 15255999
[TBL] [Abstract][Full Text] [Related]
34. Large-scale molecular comparison of human schwann cells to malignant peripheral nerve sheath tumor cell lines and tissues.
Miller SJ; Rangwala F; Williams J; Ackerman P; Kong S; Jegga AG; Kaiser S; Aronow BJ; Frahm S; Kluwe L; Mautner V; Upadhyaya M; Muir D; Wallace M; Hagen J; Quelle DE; Watson MA; Perry A; Gutmann DH; Ratner N
Cancer Res; 2006 Mar; 66(5):2584-91. PubMed ID: 16510576
[TBL] [Abstract][Full Text] [Related]
35. TYK2 promotes malignant peripheral nerve sheath tumor progression through inhibition of cell death.
Qin W; Godec A; Zhang X; Zhu C; Shao J; Tao Y; Bu X; Hirbe AC
Cancer Med; 2019 Sep; 8(11):5232-5241. PubMed ID: 31278855
[TBL] [Abstract][Full Text] [Related]
36. Spatially Resolved Transcriptomics Enables Dissection of Genetic Heterogeneity in Stage III Cutaneous Malignant Melanoma.
Thrane K; Eriksson H; Maaskola J; Hansson J; Lundeberg J
Cancer Res; 2018 Oct; 78(20):5970-5979. PubMed ID: 30154148
[TBL] [Abstract][Full Text] [Related]
37. Integrated Epigenetic and Transcriptomic Analysis Identifies
Brockman QR; Rytlewski JD; Milhem M; Monga V; Dodd RD
JCO Precis Oncol; 2024 May; 8():e2300325. PubMed ID: 38820476
[TBL] [Abstract][Full Text] [Related]
38. A misdiagnosed melanoma: a case of cutaneous epithelioid malignant peripheral nerve sheath tumor.
Linos K; Warren S
Dermatol Online J; 2015 Apr; 21(4):. PubMed ID: 25933073
[TBL] [Abstract][Full Text] [Related]
39. DNA Methylation Levels of Melanoma Risk Genes Are Associated with Clinical Characteristics of Melanoma Patients.
de Araújo ÉS; Pramio DT; Kashiwabara AY; Pennacchi PC; Maria-Engler SS; Achatz MI; Campos AH; Duprat JP; Rosenberg C; Carraro DM; Krepischi AC
Biomed Res Int; 2015; 2015():376423. PubMed ID: 26106605
[TBL] [Abstract][Full Text] [Related]
40. Aberrant demethylation and expression of MAGEB2 in a subset of malignant peripheral nerve sheath tumors from neurofibromatosis type 1.
Nobeyama Y; Nakagawa H
J Dermatol Sci; 2016 Feb; 81(2):118-23. PubMed ID: 26642794
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
